Lupin Limited (BSE: 500257) (NSE: LUPIN) announced the completion of its acquisition of VISUfarma B.V., a European specialty pharmaceutical company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE